CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
MIRACLE aims to enhance precision medicine for cardiometabolic diseases by targeting specific inflammatory pathways. It leverages advances in single cell biology and multi-omics analysis to identify and address disease-related cellular subsets, while training young scientists in innovative research methodologies and tr…
The benefit of targeting inflammatory pathways in cardiometabolic disease on top of traditional healthcare and medication is evident from recent clinical studies.
However, generalized blocking of inflammation also impacts on patients’ defense against infections and other immune-associated pathologies, such as cancer.
Clearly, more precise interventions that target disease-specific cellular subsets and mechanisms are eagerly awaited. MIRACLE’s focus on innovation is to pave the way to precision m…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Maastricht
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, Lille
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
UNIVERSITY OF EASTERN FINLAND (UEF)
Finland, KUOPIO
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAT BONN
Germany, Bonn
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
